Click to Share
 

Filter News
Show All Results
News By Country
News By Tag
Rare Disease Remove


January 2022
ThWeTuMoSuSaFr
27262524232221

Public Company News

Business Press Releases

Rare Disease Press Releases

Exclusive News
Topics Locations Industries Dates

By NEUROLIXIS
A research team specialized in the study of nervous system disorders has found that NLX-112, a serotonin 5-HT1A receptor agonist developed by Neurolixis, reversed motor deficits in a transgenic model of Spinocerebellar ataxia3 (SCA3), a rare genetic...

Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share